• European Commission grants approval for Gotenfia®, a golimumab biosimilar to Simponi® that was developed by Bio-Thera and will be marketed by STADA• Launch preparations are underway to bring the second approved golimumab biosimilar to patients acro...
View Details· This new agreement marksthe fourth product in the partnership and introduces a potential cost-effectivealternative to oneof the world’s top-selling biologics—broadening access to specialty care forpatients with chronic inflammatory diseases. · The ...
· CHMP positive opinion is based on a robust analytical,non-clinical and clinical data package comparing to the reference product Stelara® Guangzhou,China– June , 2024 –Bio-TheraSolutions Inc.USYMRO® USYMRO®. “Bio-Therais committed to being one of th...
Download Poster_Safety and efficacy of BAT8006, a folate receptor α (FRα) antibody drug conjugate, in patients with platinum-resistant ovarian cancer: Update on the dose optimization/expansion cohort of BAT-8006-001-CR trial.Download Poster_BAT8008, ...
